We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $133B
1-Year Est. Return 43.5%
This Fund
S&P 500
This Quarter Est. Return
-14.6%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$68.5B
AUM Growth
-$9.16B
Cap. Flow
+$4.06B
Cap. Flow %
5.93%
Top 10 Hldgs %
21.45%
Holding
3,375
New
359
Increased
2,433
Reduced
285
Closed
282

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$124M
2
AAPL icon
Apple
AAPL
+$110M
3
MSFT icon
Microsoft
MSFT
+$104M
4
AMZN icon
Amazon
AMZN
+$71.3M
5
WBD icon
Warner Bros
WBD
+$69.6M

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$61.6M
2
CERN
Cerner Corp
CERN
+$50.9M
3
NXPI icon
NXP Semiconductors
NXPI
+$31.4M
4
AZPN
ASPEN TECHNOLOGY INC
AZPN
+$30.4M
5
YUMC icon
Yum China
YUMC
+$16.3M

Sector Composition

Rank Sector Weight
1 Technology 23.13%
2 Healthcare 14.42%
3 Financials 13.45%
4 Consumer Discretionary 10.49%
5 Industrials 9.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LMNR icon
3176
Limoneira
LMNR
$250M
-19,218
Closed -$282K
LVO icon
3177
LiveOne
LVO
$59.4M
-4,952
Closed -$40K
MBIO icon
3178
Mustang Bio
MBIO
$4.5M
-95
Closed -$72K
LITS
3179
Lite Strategy Inc
LITS
$30.5M
-5,493
Closed -$66K
RJET
3180
Republic Airways Holdings
RJET
$964M
-2,807
Closed -$185K
MFG icon
3181
Mizuho Financial
MFG
$134B
-22,650
Closed -$58K
MG icon
3182
Mistras Group
MG
$584M
-24,678
Closed -$163K
KG
3183
Kestrel Group
KG
$60.5M
-3,089
Closed -$149K
DFTX
3184
Definium Therapeutics
DFTX
$5.9B
-20,112
Closed -$335K
MTRX icon
3185
Matrix Service
MTRX
$328M
-36,650
Closed -$301K
MUFG icon
3186
Mitsubishi UFJ Financial
MUFG
$260B
-18,442
Closed -$114K
NCMI icon
3187
National CineMedia
NCMI
$252M
-8,151
Closed -$207K
NGNE icon
3188
Neurogene
NGNE
$713M
-2,073
Closed -$78K
NNBR icon
3189
NN Inc
NNBR
$298M
-57,949
Closed -$167K
NRIM icon
3190
Northrim BanCorp
NRIM
$601M
-32,788
Closed -$357K
NVEC icon
3191
NVE Corp
NVEC
$563M
-5,268
Closed -$287K
IMDX
3192
Insight Molecular Diagnostics
IMDX
$121M
-3,018
Closed -$90K
OLMA icon
3193
Olema Pharmaceuticals
OLMA
$920M
-28,682
Closed -$122K
OMER icon
3194
Omeros
OMER
$1.26B
-72,153
Closed -$434K
ORIC icon
3195
Oric Pharmaceuticals
ORIC
$1.42B
-38,871
Closed -$208K
ORMP icon
3196
Oramed Pharmaceuticals
ORMP
$182M
-34,046
Closed -$294K
PASG icon
3197
Passage Bio
PASG
$14.7M
-2,328
Closed -$144K
PAVM icon
3198
PAVmed
PAVM
$33.9M
-144
Closed -$85K
PBYI icon
3199
Puma Biotechnology
PBYI
$450M
-38,775
Closed -$112K
PKOH icon
3200
Park-Ohio Holdings
PKOH
$718M
-11,653
Closed -$164K

Similar funds

RhumbLine Advisers's Q2 2022 Portfolio in Review

As of Q2 2022, RhumbLine Advisers held 3,375 positions worth $68.5B, down 12% from $77.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

RhumbLine Advisers deployed $4.06B of net new capital in Q2 2022, opening 359 new positions and adding to 2,433 existing holdings. Its largest new stake was Aspen Technology Inc: 81,883 shares worth $15M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was AT&T, an estimated $61.6M trimmed.

  • RhumbLine Advisers's largest Q2 2022 buy was Aspen Technology Inc: 81,883 shares worth $15M.
  • RhumbLine Advisers added most to Linde in Q2 2022, an estimated $124M increase.
  • RhumbLine Advisers's biggest Q2 2022 reduction was AT&T, cutting an estimated $61.6M.
  • RhumbLine Advisers fully exited Cerner Corp in Q2 2022, selling an estimated $50.9M.
  • RhumbLine Advisers's ten largest holdings make up 21% of its $68.5B portfolio in Q2 2022.
  • RhumbLine Advisers opened 359 new positions and closed 282 in Q2 2022.
  • RhumbLine Advisers's portfolio value fell 12% quarter-over-quarter to $68.5B.

Based on RhumbLine Advisers's 13F filing for Q2 2022, filed 11 Aug 2022.